Annual Cash & Cash Equivalents
$292.00 M
-$99.88 M-25.49%
31 December 2023
Summary:
Arcturus Therapeutics Holdings annual cash & cash equivalents is currently $292.00 million, with the most recent change of -$99.88 million (-25.49%) on 31 December 2023. During the last 3 years, it has fallen by -$170.89 million (-36.92%). ARCT annual cash & cash equivalents is now -36.92% below its all-time high of $462.89 million, reached on 31 December 2020.ARCT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$237.18 M
-$23.15 M-8.89%
30 September 2024
Summary:
Arcturus Therapeutics Holdings quarterly cash and cash equivalents is currently $237.18 million, with the most recent change of -$23.15 million (-8.89%) on 30 September 2024. Over the past year, it has dropped by -$74.74 million (-23.96%). ARCT quarterly cash and cash equivalents is now -49.19% below its all-time high of $466.84 million, reached on 31 March 2021.ARCT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARCT Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.5% | -24.0% |
| 3 y3 years | -36.9% | -42.7% |
| 5 y5 years | +695.5% | +219.8% |
ARCT Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -36.9% | at low | -42.7% | at low |
| 5 y | 5 years | -36.9% | +695.5% | -49.2% | +298.8% |
| alltime | all time | -36.9% | >+9999.0% | -49.2% | >+9999.0% |
Arcturus Therapeutics Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $237.18 M(-8.9%) |
| June 2024 | - | $260.33 M(-9.7%) |
| Mar 2024 | - | $288.40 M(-1.2%) |
| Dec 2023 | $292.00 M(-25.5%) | $292.00 M(-6.4%) |
| Sept 2023 | - | $311.92 M(-3.6%) |
| June 2023 | - | $323.47 M(-1.4%) |
| Mar 2023 | - | $327.94 M(-16.3%) |
| Dec 2022 | $391.88 M(+5.8%) | $391.88 M(+64.9%) |
| Sept 2022 | - | $237.68 M(-16.2%) |
| June 2022 | - | $283.49 M(-11.3%) |
| Mar 2022 | - | $319.68 M(-13.7%) |
| Dec 2021 | $370.49 M(-20.0%) | $370.49 M(-10.5%) |
| Sept 2021 | - | $413.88 M(-4.5%) |
| June 2021 | - | $433.57 M(-7.1%) |
| Mar 2021 | - | $466.84 M(+0.9%) |
| Dec 2020 | $462.89 M(+548.7%) | $462.89 M(+50.8%) |
| Sept 2020 | - | $307.02 M(+125.6%) |
| June 2020 | - | $136.11 M(+128.9%) |
| Mar 2020 | - | $59.47 M(-16.7%) |
| Dec 2019 | $71.35 M | $71.35 M(-3.8%) |
| Sept 2019 | - | $74.17 M(+32.8%) |
| June 2019 | - | $55.84 M(+78.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $31.22 M(-15.0%) |
| Dec 2018 | $36.71 M(+47.0%) | $36.71 M(+21.0%) |
| Sept 2018 | - | $30.33 M(+21.5%) |
| Dec 2017 | $24.96 M(+199.2%) | $24.96 M(+730.2%) |
| Sept 2017 | - | $3.01 M(-15.7%) |
| June 2017 | - | $3.57 M(-23.7%) |
| Mar 2017 | - | $4.67 M(-44.0%) |
| Dec 2016 | $8.35 M(-49.9%) | $8.35 M(+90.7%) |
| Sept 2016 | - | $4.38 M(-71.0%) |
| June 2016 | - | $15.09 M(+11.9%) |
| Mar 2016 | - | $13.49 M(-19.0%) |
| Dec 2015 | $16.66 M(+665.5%) | $16.66 M(+67.1%) |
| Sept 2015 | - | $9.97 M(+16.3%) |
| June 2015 | - | $8.57 M(+293.8%) |
| Dec 2014 | $2.18 M(-90.2%) | $2.18 M(-19.8%) |
| Sept 2014 | - | $2.71 M(-60.7%) |
| June 2014 | - | $6.91 M(-33.5%) |
| Mar 2014 | - | $10.39 M(-53.0%) |
| Dec 2013 | $22.09 M(>+9900.0%) | $22.09 M(+386.7%) |
| Sept 2013 | - | $4.54 M(-74.2%) |
| June 2013 | - | $17.59 M(>+9900.0%) |
| Dec 2012 | $97.00 K(+76.4%) | $97.00 K |
| Dec 2011 | $55.00 K | - |
FAQ
- What is Arcturus Therapeutics Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual cash & cash equivalents year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly cash and cash equivalents year-on-year change?
What is Arcturus Therapeutics Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of ARCT is $292.00 M
What is the all time high annual cash & cash equivalents for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual cash & cash equivalents is $462.89 M
What is Arcturus Therapeutics Holdings annual cash & cash equivalents year-on-year change?
Over the past year, ARCT annual cash & cash equivalents has changed by -$99.88 M (-25.49%)
What is Arcturus Therapeutics Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ARCT is $237.18 M
What is the all time high quarterly cash and cash equivalents for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly cash and cash equivalents is $466.84 M
What is Arcturus Therapeutics Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, ARCT quarterly cash and cash equivalents has changed by -$74.74 M (-23.96%)